// App-Quantinova.ai

: CLINICAL EFFICACY OF LEFLUNOMIDE/HYDROXYCHLOROQUINE COMBINATION THERAPY IN PRIMARY SJOGREN’S SYNDROME IS PREDICTED BY SERUM PROTEOME BIOMARKERS – RESULTS FROM REPURPSS-I

Researchers

Presenter

  • Joel van Roon

Principal Investigators

  • Eefje van der Heijden

  • Sofie Blokland

  • Ana Lopes

  • Frederique Moret

  • Paco Welsing

  • Nard Janssen

  • Toine Rosenberg

  • Aridaman Pandit

  • Weiyang Tao

  • Maarten Hillen

  • Aike A. Kruize

  • Timothy R. Radstake

Medical Centers

  • University Medical Center Utrecht, Utrecht, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • HWA-486

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved